Eisai and Purdue Pharma to Present Latest Phase I Clinical Data on Lemborexant at 32nd Annual Sleep Meeting

TOKYO May 23 2018 JCN Newswire Eisai Co. Ltd. and Purdue Pharma L.P. today announced they will present the latest data from two key Phase I clinical studies Study 108 and Study 106 of in...
Read the full story: Bioportfolio Latest News